117 related articles for article (PubMed ID: 29775647)
1. Exposure to imipenem/cilastatin causes nephrotoxicity and even urolithiasis in Wistar rats.
Tahri A; Lahyani A; Kallel R; Ayadi F; Boudawara T; Sahnoun Z
Toxicology; 2018 Jul; 404-405():59-67. PubMed ID: 29775647
[TBL] [Abstract][Full Text] [Related]
2. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
[TBL] [Abstract][Full Text] [Related]
3. A carbapenem antibiotic imipenem/cilastatin induces an oxidative stress-status and gonadotoxic effects in « wistar » rats.
Tahri A; Ksouda K; Kallel R; Daoud S; Boudawara T; Zeghal KM; Sahnoun Z
Biomed Pharmacother; 2017 Nov; 95():308-316. PubMed ID: 28858728
[TBL] [Abstract][Full Text] [Related]
4. Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats.
Nakamura T; Hashimoto Y; Kokuryo T; Inui KI
Pharm Res; 1998 May; 15(5):734-8. PubMed ID: 9619782
[TBL] [Abstract][Full Text] [Related]
5. Renal tolerance of imipenem/cilastatin and other beta-lactam antibiotics in rats.
Sack K; Herhahn J; Marre R; Schulz E
Infection; 1985; 13 Suppl 1():S156-60. PubMed ID: 3863794
[TBL] [Abstract][Full Text] [Related]
6. Reduction of cyclosporine-induced nephrotoxicity by cilastatin following clinical heart transplantation.
Markewitz A; Hammer C; Pfeiffer M; Zahn S; Drechsel J; Reichenspurner H; Reichart B
Transplantation; 1994 Mar; 57(6):865-70. PubMed ID: 8154033
[TBL] [Abstract][Full Text] [Related]
7. Does nephrotoxicity develop less frequently when vancomycin is combined with imipenem-cilastatin than with meropenem? A comparative study.
Hakeam HA; AlAnazi L; Mansour R; AlFudail S; AlMarzouq F
Infect Dis (Lond); 2019 Aug; 51(8):578-584. PubMed ID: 31122098
[No Abstract] [Full Text] [Related]
8. Flucloxacillin worsens while imipenem-cilastatin protects against vancomycin-induced kidney injury in a translational rat model.
Pais GM; Marianski S; Valdez K; Melicor RP; Liu J; Rohani R; Chang J; Tong SYC; Davis JS; Scheetz MH
Br J Pharmacol; 2024 Mar; 181(5):670-680. PubMed ID: 37696768
[TBL] [Abstract][Full Text] [Related]
9. Modification of natural immunity in mice by imipenem/cilastatin.
Ortega E; de Pablo MA; Gallego AM; Alvarez C; Pancorbo PL; Ruiz-Bravo A; de Cienfuegos GA
J Antibiot (Tokyo); 1997 Jun; 50(6):502-8. PubMed ID: 9268007
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits.
Toyoguchi T; Takahashi S; Hosoya J; Nakagawa Y; Watanabe H
Antimicrob Agents Chemother; 1997 Sep; 41(9):1985-90. PubMed ID: 9303398
[TBL] [Abstract][Full Text] [Related]
11. Steady-state pharmacokinetics of intramuscular imipenem-cilastatin in elderly patients with various degrees of renal function.
Pietroski NA; Graziani AL; Lawson LA; Bland JA; Rogers JD; MacGregor RR
Antimicrob Agents Chemother; 1991 May; 35(5):972-5. PubMed ID: 1854179
[TBL] [Abstract][Full Text] [Related]
12. Effects of beta-lactam antibiotics imipenem/cilastatin and cefodizime on cellular and humoral immune responses in BALB/c-mice.
Grochla I; Ko HL; Beuth J; Roszkowski K; Roszkowski W; Pulverer G
Zentralbl Bakteriol; 1990 Nov; 274(2):250-8. PubMed ID: 2085374
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxic and peroxidative potential of meropenem and imipenem/cilastatin in rat and human renal cortical slices and microsomes.
Yousif T; Pooyeh S; Hannemann J; Baumann J; Tauber R; Baumann K
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):475-86. PubMed ID: 10543314
[TBL] [Abstract][Full Text] [Related]
14. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
Humanes B; Lazaro A; Camano S; Moreno-Gordaliza E; Lazaro JA; Blanco-Codesido M; Lara JM; Ortiz A; Gomez-Gomez MM; Martín-Vasallo P; Tejedor A
Kidney Int; 2012 Sep; 82(6):652-63. PubMed ID: 22718191
[TBL] [Abstract][Full Text] [Related]
15. Animal model for evaluating the convulsive liability of beta-lactam antibiotics.
Williams PD; Bennett DB; Comereski CR
Antimicrob Agents Chemother; 1988 May; 32(5):758-60. PubMed ID: 3395104
[TBL] [Abstract][Full Text] [Related]
16. Induction of audiogenic seizures in imipenem/cilastatin-treated rats.
Zivanovic D; Stanojlovic O; Stojanovic J; Susic V
Epilepsy Behav; 2004 Apr; 5(2):151-8. PubMed ID: 15123014
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment.
Badiou S; Bellet H; Lehmann S; Cristol JP; Jaber S
Clin Chem Lab Med; 2005; 43(3):332-4. PubMed ID: 15843241
[TBL] [Abstract][Full Text] [Related]
18. Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects.
Rizk ML; Rhee EG; Jumes PA; Gotfried MH; Zhao T; Mangin E; Bi S; Chavez-Eng CM; Zhang Z; Butterton JR
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311084
[TBL] [Abstract][Full Text] [Related]
19. The Nephroprotective Effect of N-Acetyl-L-Cysteine and Atorvastatin against Imipenem induced Nephrotoxicity.
Rababa’h AM; Hijjawi TB; Alzoubi KH; Al Demour S; Ababneh MA
Curr Mol Pharmacol; 2018; 11(2):155-161. PubMed ID: 28762308
[TBL] [Abstract][Full Text] [Related]
20. Cilastatin protects against imipenem-induced nephrotoxicity
Huo X; Meng Q; Wang C; Zhu Y; Liu Z; Ma X; Ma X; Peng J; Sun H; Liu K
Acta Pharm Sin B; 2019 Sep; 9(5):986-996. PubMed ID: 31649848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
